Holen Sie sich die Stockscreener-App
11.33
1.34%
0.15
Schlusskurs vom Vortag:
$11.18
Offen:
$11.06
24-Stunden-Volumen:
521.45K
Relative Volume:
0.71
Marktkapitalisierung:
$1.39B
Einnahmen:
$1.12B
Nettoeinkommen (Verlust:
$5.00M
KGV:
-
EPS:
-
Netto-Cashflow:
$-383.00M
1W Leistung:
+7.09%
1M Leistung:
+25.89%
6M Leistung:
-34.77%
1J Leistung:
-29.58%
1-Tages-Spanne:
$10.94
$11.47
1-Wochen-Bereich:
$10.45
$11.47
52-Wochen-Spanne:
$7.33
$23.22
Indivior Plc Stock (INDV) Company Profile
Vergleichen Sie INDV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INDV
Indivior Plc
|
11.33 | 1.39B | 1.12B | 5.00M | -383.00M | 0.00 |
|
ZTS
Zoetis Inc
|
176.74 | 80.59B | 9.15B | 2.43B | 2.31B | 4.92 |
|
HLN
Haleon Plc Adr
|
9.72 | 44.17B | 14.26B | 1.55B | 0 | 0.3327 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.57 | 42.61B | 30.27B | 1.93B | 3.45B | 0.444 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.57 | 18.77B | 16.77B | -959.00M | 1.37B | -2.00 |
|
VTRS
Viatris Inc
|
13.22 | 15.73B | 15.05B | -883.30M | 1.89B | 1.53 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-23 | Eingeleitet | Piper Sandler | Overweight |
| 2024-04-03 | Eingeleitet | Craig Hallum | Buy |
| 2023-07-13 | Eingeleitet | Northland Capital | Outperform |
Indivior Plc Aktie (INDV) Neueste Nachrichten
Clark Estates Inc. NY Takes Position in Indivior PLC (NASDAQ:INDV) - MarketBeat
Indivior’s Strategic Share Repurchase Initiative - TipRanks
INDV Investors Have Opportunity to Lead Indivior PLC Securities Fraud Lawsuit with the Schall Law Firm - GuruFocus.com
(INDV) Trading Report - Stock Traders Daily
Levi & Korsinsky Announces the Filing of a Securities Class Acti - GuruFocus.com
Valence8 US LP Buys New Position in Indivior PLC (NASDAQ:INDV) - MarketBeat
Indivior Announces Q3 2024 Financial Results - GuruFocus.com
Indivior to Engage with Investors at Healthcare Conference - TipRanks
Indivior's SUBLOCADE® Rapid Induction/Alternative Injection Site - GuruFocus.com
Shareholders that lost money on Indivior PLC(INDV) should contac - GuruFocus.com
Indivior Responds to Publication of a Letter by Oaktree Capital - GuruFocus.com
The Gross Law Firm Announces the Filing of a Securities Class Ac - GuruFocus.com
Addex Stock Soars on Crucial Update From Indivior Research Deal - MSN
Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024 - The Malaysian Reserve
Naloxone Market Growth in Future Scope 2024-2031 | EMERGENT, - openPR
Indivior shares Sublocade trial findings at CSAM conference - TipRanks
Indivior PLC Executes Strategic Share Repurchase - TipRanks
Indivior (LON:INDV) Stock Passes Above 50 Day Moving AverageHere's Why - MarketBeat
Substance Abuse Treatment Market Future Business - openPR
Indivior’s Voting Rights Shift with Madison Avenue - TipRanks
Suboxone Tooth Decay Lawsuit - Lawsuit Information Center Blog
A Piece Of The Puzzle Missing From Indivior PLC's (LON:INDV) 35% Share Price Climb - Simply Wall St
SCOPIA CAPITAL MANAGEMENT LP Adjusts Stake in Indivior PLC - GuruFocus.com
Indivior Extends Board Tenure Amidst Shareholder Changes - TipRanks
Richmond InnoChesterfield pharma company Indivior subject to activist shareholder push - The Business Journals
Learn to Evaluate (INDV) using the Charts - Stock Traders Daily
Indivior PLC (INDV) Shares Down 3.04% on Nov 12 - GuruFocus.com
Deerfield’s Strategic Stake Acquisition in Indivior - TipRanks
Indivior jumps amid investor letter, takeover speculation (update) - MSN
Indivior (LON:INDV) Shares Pass Below 200-Day Moving AverageShould You Sell? - MarketBeat
Indivior Responds to Publication of a Letter by Oaktree Capital Management to the Board of Indivior - The Malaysian Reserve
Indivior Boosts Shareholder Value with Repurchase Program - TipRanks
Oaktree Capital urges UK's Indivior to refresh board - Reuters
Indivior says it remains open-minded on activist investor Oaktree's proposals - Proactive Investors USA
Indivior Engages with Oaktree on Value Proposals - TipRanks
Indivior jumps amid takeover speculation - MSN
Oaktree Capital calls on Indivior to refresh board of directors - ShareCast
A Setback for Suboxone Film Plaintiffs: Northern District of Ohio's Dismissal Decision - LawyersandSettlements.com
AlphaCentric Advisors LLC Invests $2.36 Million in Indivior PLC (NASDAQ:INDV) - MarketBeat
Indivior completes refinancing of secured term loan - Marketscreener.com
Indivior Extends Its Debt Maturity With Refinancing of Term Loan - Bloomberg
Indivior Boosts Liquidity with $400 Million Refinancing - TipRanks
Indivior PLC Completes Refinance of Secured Term Loan - Marketscreener.com
VELA Investment Management LLC Acquires 108,435 Shares of Indivior PLC (NASDAQ:INDV) - MarketBeat
When the Price of (INDV) Talks, People Listen - Stock Traders Daily
Indivior Announces Total Voting Rights Update - TipRanks
Indivior (LON:INDV) Stock Price Crosses Below 200 Day Moving AverageWhat's Next? - MarketBeat
Sublocade shows promise in opioid disorder recovery By Investing.com - Investing.com Australia
Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Abuse Prevention Month - The Malaysian Reserve
Finanzdaten der Indivior Plc-Aktie (INDV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.83%
1.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):